Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Nippon Indosari Corpindo Tbk. (ROTI) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Nippon Indosari Corpindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 6.8K 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp585 (market cap 3.62T, 94K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 11.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Nippon Indosari Corpindo Tbk. is more actively traded (94K versus 6.8K). Which is the better fit depends on your goals.

DGNSROTI
Market Cap
319B3.62T
Volume
6.8K94K
Lot
68940
Turnover
1.56M55.18M
Average Price
229587.06
Value
1.56M55.18M
Indicative Equilibrium Price
232
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
ROTI
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Nippon Indosari Corpindo Tbk.

PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on ROTI